3,086
Views
7
CrossRef citations to date
0
Altmetric
Expert Opinions

Potential of circulating biomarkers in liquid biopsy diagnostics

&
Pages 187-189 | Received 29 Jun 2018, Accepted 25 Jul 2018, Published online: 04 Oct 2018

References

  • Sun Y , HaglundTA, RogersAJ, GhanimAF, SethuP. Review: Microfluidics technologies for blood-based cancer liquid biopsies. Analytica Chimica Acta1012, 10–29 (2018).
  • Zhang W , XiaW, LvZ, NiC, XinY, YangL. Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes?Cell. Physiol. Biochem.41(2), 755–768 (2017).
  • Cohen JD , LiL, WangYet al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science359(6378), 926–930 (2018).
  • Pi C , ZhangM-f, PengX-x, ZhangY-c, XuC-r, ZhouQ. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?Exp. Rev. Mol. Diag.17(12), 1089–1096 (2017).
  • Melo SA , LueckeLB, KahlertCet al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature523, 177 (2015).
  • Yeo JC , Kenry, ZhaoZ, ZhangP, WangZ, LimCT. Label-free extraction of extracellular vesicles using centrifugal microfluidics. Biomicrofluidics12(2), 024103 (2018).
  • Babayan A , PantelK. Advances in liquid biopsy approaches for early detection and monitoring of cancer. Genome Med.10(1), 21 (2018).
  • Wan JCM , MassieC, Garcia-CorbachoJet al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer17, 223 (2017).